Literature DB >> 20861124

Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation.

P Trebble1, L Matthews, J Blaikley, A W O Wayte, G C M Black, A Wilton, D W Ray.   

Abstract

CONTEXT: Familial glucocorticoid resistance is a rare condition with a typical presentation of women with hirsutism and hypertension, with or without hypokalemia.
OBJECTIVE: The aim was to determine the cause of apparent glucocorticoid resistance in a young woman. PATIENTS AND METHODS: We studied a family with a novel glucocorticoid receptor (GR) mutation and a surprisingly mild phenotype. Their discovery resulted from serendipitous measurement of serum cortisol with little biochemical or clinical evidence for either hyperandrogenism or mineralocorticoid excess.
RESULTS: The causative mutation was identified as a frameshift mutation in exon 6. Transformed peripheral blood lymphocytes were generated to analyze GR expression in vitro. Carriers of the mutation had less full-length GR, but the predicted mutant GR protein was not detected. However, this does not exclude expression in vivo, and so the mutant GR (Δ612GR) was expressed in vitro. Simple reporter gene assays suggested that Δ612GR has dominant negative activity. Δ612GR was not subject to ligand-dependent Ser211 phosphorylation or to ligand-dependent degradation. A fluorophore-tagged construct showed that Δ612GR did not translocate to the nucleus in response to ligand and retarded translocation of the wild-type GR. These data suggest that Δ612GR is not capable of binding ligand and exerts dominant negative activity through heterodimerization with wild-type GR.
CONCLUSION: Therefore, we describe a novel, naturally occurring GR mutation that results in familial glucocorticoid resistance. The mutant GR protein, if expressed in vivo, is predicted to exert dominant negative activity by impairing wild-type GR nuclear translocation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861124      PMCID: PMC4110505          DOI: 10.1210/jc.2010-0705

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

1.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

Authors:  V Doucas; Y Shi; S Miyamoto; A West; I Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma.

Authors:  Q A Hamid; S E Wenzel; P J Hauk; A Tsicopoulos; B Wallaert; J J Lafitte; G P Chrousos; S J Szefler; D Y Leung
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

3.  A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.

Authors:  Alessandra Vottero; Tomoshige Kino; Herve Combe; Pierre Lecomte; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

Review 4.  Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach.

Authors:  Elisabeth F C van Rossum; Steven W J Lamberts
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-12       Impact factor: 4.690

Review 5.  Steroid receptor interactions with heat shock protein and immunophilin chaperones.

Authors:  W B Pratt; D O Toft
Journal:  Endocr Rev       Date:  1997-06       Impact factor: 19.871

6.  A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.

Authors:  Evangelia Charmandari; Annaswamy Raji; Tomoshige Kino; Takamasa Ichijo; Anatoly Tiulpakov; Keith Zachman; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

7.  Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.

Authors:  T Kino; R H Stauber; J H Resau; G N Pavlakis; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

8.  Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.

Authors:  M Ruiz; U Lind; M Gåfvels; G Eggertsen; J Carlstedt-Duke; L Nilsson; M Holtmann; P Stierna; A C Wikström; S Werner
Journal:  Clin Endocrinol (Oxf)       Date:  2001-09       Impact factor: 3.478

9.  Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype.

Authors:  Pia J Hauk; Elena Goleva; Ian Strickland; Alessandra Vottero; George P Chrousos; Kevin O Kisich; Donald Y M Leung
Journal:  Am J Respir Cell Mol Biol       Date:  2002-09       Impact factor: 6.914

10.  Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1).

Authors:  Sarah K McMahon; Carel J Pretorius; Jacobus P J Ungerer; Nathaniel J Salmon; Louise S Conwell; Michael A Pearen; Jennifer A Batch
Journal:  J Clin Endocrinol Metab       Date:  2009-11-20       Impact factor: 5.958

View more
  6 in total

1.  Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy.

Authors:  Laura C Matthews; Andrew A Berry; David J Morgan; Toryn M Poolman; Kerstin Bauer; Frederike Kramer; David G Spiller; Rachel V Richardson; Karen E Chapman; Stuart N Farrow; Michael R Norman; Andrew J K Williamson; Anthony D Whetton; Stephen S Taylor; Jan P Tuckermann; Michael R H White; David W Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 2.  An unexpected, mild phenotype of glucocorticoid resistance associated with glucocorticoid receptor gene mutation case report and review of the literature.

Authors:  Ágnes Molnár; Attila Patócs; István Likó; Gábor Nyírő; Károly Rácz; Miklós Tóth; Beatrix Sármán
Journal:  BMC Med Genet       Date:  2018-03-06       Impact factor: 2.103

Review 3.  Role of glucocorticoid receptor mutations in hypertension and adrenal gland hyperplasia.

Authors:  Sophia Verouti; Edith Hummler; Paul-Emmanuel Vanderriele
Journal:  Pflugers Arch       Date:  2022-06-22       Impact factor: 4.458

4.  A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response.

Authors:  Brian B Griffiths; Peter J Schoonheim; Limor Ziv; Lisa Voelker; Herwig Baier; Ethan Gahtan
Journal:  Front Behav Neurosci       Date:  2012-10-11       Impact factor: 3.558

5.  Functional characterization of canine wild type glucocorticoid receptor and an insertional mutation in a dog.

Authors:  Kosei Yamanaka; Masaru Okuda; Takuya Mizuno
Journal:  BMC Vet Res       Date:  2019-10-24       Impact factor: 2.741

6.  Glucocorticoid receptor isoforms direct distinct mitochondrial programs to regulate ATP production.

Authors:  David J Morgan; Toryn M Poolman; Andrew J K Williamson; Zichen Wang; Neil R Clark; Avi Ma'ayan; Anthony D Whetton; Andrew Brass; Laura C Matthews; David W Ray
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.